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Background: Crassocephalum bauchiense is a flowering plant, found in the West Region of Cameroon. Previous
studied has highlighted the antibacterial and the dermal toxicological safety as well as the immunomodulatory
activities of the ethyl acetate extract of its dry leaves. As an extension of the previous researches, the current work
has been undertaken to evaluate the in vitro antifungal and antioxidant activities of C. bauchiense dried leaves ethyl
acetate extract and fractions.
Methods: The extract was obtained by maceration in ethyl acetate and further fractionated into six fractions labeled F1
to F6 by flash chromatography. The antifungal activity of the extract and fractions against yeasts and dermatophytes
was evaluated using broth microdilution method. Antioxidant activity was evaluated using 2,2-diphenyl-1-picrylhydrazyl
(DPPH), nitric oxide (NO) and β-carotene - linoleic acid assays.
Results: The extract (MIC = 0.125 - 4 mg/ml) was found to be more active on dermatophytes and yeasts
compared to the fractions. The ethyl acetate extract and fractions exhibited strong scavenging activity on DPPH
(CI50 = 28.57 - 389.38 μg/ml). The fractions F3 and F6 expressed best antioxidant activity on DPPH radicals compared to
the crude extract.
Conclusion: The results of these findings clearly showed that C. bauchiense ethyl acetate extract has a significant
antifungal and antioxidant activity. It is therefore a source of active compounds that might be used as antifungal and
antioxidant agents.
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Crassocephalum bauchiense is a species of flowering
plant in the Asteraceae family. Earlier studies on this
plant reported the immunomodulatory activity [1] as
well as in vitro and in vivo antibacterial activity [2].
Also the antimicrobial and antioxidant activity of some
species of the Crassocephalum genus is well estab-
lished [3-5].
In the last two decades, the incidence of infectious dis-
eases caused by dermatophytes and yeasts has increased
considerably worldwide [6]. These diseases are associated* Correspondence: moraysi@yahoo.fr
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reproduction in any medium, provided the orto great morbidity among humans with elderly and
immuno-compromised patients being the most affected.
The situation is more complicated in developing coun-
tries with poor hygienic conditions.
Free radical and reactive oxygen species (ROS) are
involved in several disorders in human. The harmful
action of the free radicals can, however be blocked by
antioxidant substances which scavenge the free radi-
cals and detoxify the organism. Current research into
free radicals has confirmed that foodstuffs rich in anti-
oxidants play an essential role in the prevention of cardio-
vascular diseases and cancers [7], and neurodegenerative
diseases, including Parkinson’s and Alzheimer’s diseases
[8] as well as inflammation. Therefore, plant-derived anti-
oxidants are now receiving a special attention [9].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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potential uses as alternative remedies for the treatment
of many infectious diseases. Particularly, the antimicro-
bial activities of plant extracts have formed the basis of
many applications [10,11]. The present work has been
undertaken to explore the antifungal and antioxidant
activities of the C. bauchiense leaves extract.
Method
Plant material
Crassocephalum bauchiense leaves were collected in
Dschang (West region of Cameroon). The species was
authenticated at the Cameroon National Herbarium in
Yaounde where a voucher specimen was deposited with
the reference number 7954/SRF/Cam.
Microorganisms
Fungal species used included eight yeast strains (Can-
dida albicans ATCC 1663, ATCC 2091, ATCC 24433, C.
krusei ATCC 6258, C. glabrata CIP 35, C. parapsilosis
ATCC 22019, C. tropicalis ATCC 750 and Cryptococcus
neoformans IP 95026), four dermatophytes strains (Tri-
chophyton mentagrophytes E 1425, Trichophyton terrestre
E 1501, Microsporum gypseum E 1420, Epidermophyton
flocosum E 1423) and one clinical isolate of Microsporu-
maudouinii. This isolate was a gift from Pasteur Insti-
tute, Cameroon.
Preparation of the plant extract
C. bauchiense leaves were dried at laboratory temperature
(20 ± 2°C) and ground into fine powder. The dried pow-
dered leaves were macerated in hexane and further in ethyl
acetate. For each solvent, the extraction time was 48 hours
at ambient conditions. The ethyl acetate extract obtained
was filtered and dried at 40°C using a vacuum evaporator.
The yield was found to be 10.25 w/w of dry leaves powder.
This extract was further fractionated using flash chroma-
tography. In so doing, 50 g of the extract was fixed on silica
gel (Merck, 70–230 mesh) and eluted throughout a silica
gel column. The elution was done using increasing solvent
polarity made of hexane, ethyl acetate and methanol mix-
ture. Fractions of 500 ml for each polarity were collected
and evaporated in a vacuum at 40°C, then mixed on the
basis of their similarities on thin layer chromatography into
six fractions labeled F1 to F6.
Antifungal activity
Yeast suspensions of about 1.5 × 108 CFU/ml (Mc Farland
turbidity standard no. 0.5) were prepared from 48 hours
culture in normal saline and diluted in Sabouraud broth
culture medium (SDA, Conda, Madrid, Spanish) to obtain
a 2.5 105 UFC/ml inoculums [12].
A suspension of conidia was prepared from 10 days
old dermatophytes culture on SDA slants (SDA, Conda,Madrid, Espagne) by using sterile physiological saline
solution. This solution was added to the slant tube
culture and the colony surface was gently swabbed
with a sterile bent glass rod to dislodge the conidia
from the hyphal mat. The suspension was transferred
to a sterile centrifuge tube. Upon centrifugation, the
volume was adjusted to 10 ml with sterile normal
saline. The final suspension of conidia was counted
with a hemocytometer cell counting chamber and
adjusted to 105 spores/ml [13].
The in vitro antifungal activity of the extract and
fractions was performed by determining the minimum
inhibitory concentrations (MIC) using broth microdilution
method [14]. The stock solutions of C. bauchiense extract
and fractions were prepared in 5% tween 80. The anti-
fungal susceptibility tests were performed in 96 well
microplates. Serial two-fold dilutions of the extract/
fractions were performed to obtain a final concentration
ranging from 16 to 0.12 mg/ml in a total volume of
100 μl/well. Fungal suspension (100 μl) in Sabouraud
broth culture medium was added in all the wells to a
final volume of 200 μl/well. The plates were incubated
at 35°C for 48 h (yeasts) and at 30°C for five days (derma-
tophytes). Minimum inhibitory concentrations (MIC) were
defined as the lowest concentrations of extract or fraction
required to prevent the visual growth of the fungi at the
end of the incubation time.
Minimum fungicidal concentrations (MFC) were
determined by sub-culturing 10 μl aliquots of the
medium drawn from wells which did not show any
growth after incubation during MIC assay and in-
cubated further for 48 hours at 35°C (yeasts) or five days
at 30°C (dermatophytes) for the appearance of growth.
The lowest concentration of the antifungal agent from
which negative growth was recorded was considered as
MFC [14].
The assays were carried out in triplicate. Nystatin
and Griseofulvin were dissolved in 5% acetone and
used as positive controls respectively for yeasts and
dermatophytes.Antioxidant activity
DPPH assay
The hydrogen atom or electron donation ability of the
extract and fractions were measured from the bleaching
of the purple colored methanol solution of DPPH. This
spectrophotometric assay uses stable radical diphenyl-
picrylhydrazyl (DPPH) as reagent [15]. One hundred
microlitres of various concentrations of the extract and
fractions in methanol was added to 900 μl of a 250 mg/ml
methanol solution of DPPH. After 30 min incubation
period at room temperature, the absorbance was read
against a blank at 517 nm. Percent scavenging of the
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equation.
I %ð Þ ¼ Ablank−Asample
Ablank
 100
Where Ablank is the absorbance of the control reaction
(containing all reagents except the test compound), and
Asample is the absorbance of the test compound.
Nitric oxide assay
Nitric oxide, generated from sodium nitroprusside in
aqueous solution at physiological pH interacts with oxy-
gen to produce nitrite ions which were measured by
Griess reagent. Sodium nitroprusside (10 mM) in stand-
ard phosphate buffer saline solution (0.025 M, pH: 7.4)
was incubated with different concentrations of extract or
fractions (10–1000 μg/ml) and the tubes were incubated
at 25°C for 5 hours. After the incubation time, 0.5 ml of
incubated solution was removed and diluted with 0.5 ml
of Griess reagent and incubated for 10 min. The absorb-
ance was further read at 546 nm. Percentage inhibition
(I %) was calculated using the above formula for DPPH
assay [16].
β Carotene – linoleic acid assay
In this assay, antioxidant capacity is determined by meas-
uring the inhibition of the volatile organic compounds and
the conjugated diene hydroperoxides arising from linoleic
acid oxidation [17]. A stock solution of β-carotene – lino-
leic acid mixture was prepared as follows: a solution of β
carotene was prepared at 15 mg/ml using chloroform
(HPLC grade), 75 μl linoleic acid and 600 mg Tween 80
was added to the solution. Chloroform was completely
evaporated using a vacuum evaporator. Then, 150 ml
distilled water saturated with oxygen (30 min) was added
with vigorous shaking to yield an emulsion. A volume of
2680 μl of the emulsion was dispensed into test tubes and
320 ml of the extract or fraction prepared in ethanol at
various concentrations was added and the absorbance was
obtained at 492 nm immediately and following 105 min
incubation at 55°C against blank. The antioxidative cap-
acity (I %) of the extract and fractions was calculated
using the following formula:
I %ð Þ ¼ ΔAblank−ΔAsample
ΔAblank
ΔDOblank is the difference between the absorbance
read at 0 and that read at 105 min of incubation of the
blank
ΔDOsample is the difference between the absorbance
read at 0 and that read at 105 min of incubation of the
test sampleIn each antioxidant test, the experiment was per-
formed in triplicate. Ascorbic acid and synthetic antioxi-
dant reagent butylated hydroxytoluene (BHT) were used
as positive control. The effective concentration of extract
and fractions required to scavenge radical by 50% (IC50
value) was obtained by linear regression analysis of
dose–response curve plotting between percentage inhib-
ition and concentrations.
Statistical analysis
Antioxidant experimental results are expressed as
means ± SD. The data were analyzed by one way ana-
lysis of variance (p < 0.05) and the means separated by
Waller Duncan multiple range tests (SPSS program).
Results
Antimicrobial activity
The results of the broth microdilution test are presented
in Table 1. Minimum inhibitory concentrations of the
extract range from 0.125 to 4 mg/ml while those of ac-
tive fractions range from 0.5 to 8 mg/ml. It was realized
that the extract was more active than the fractions.
Among the fractions, F3, F4 and F5 were more active.
Dermatophytes were more sensitive to C. bauchiense
ethyl acetate extract with MIC values ranging from
0.125 to 0.250 mg/ml. Among yeasts, C. albicans (ATCC
2091) and C. glabrata were more sensitive to the extract
while C. parapsilosis was most resistant. The CMF/CMI
ratio was generally less than 4 for both yeasts and
dermatophytes.
Antioxidant activity
C. bauchiense ethyl acetate extract and fractions exhib-
ited free radical scavenging activity on DPPH, NO radi-
cals and preserved β – carotene to oxidation (Table 2).
The activity was more effective on DPPH radical with
the fractions F3 and F6 being the most active. The scav-
enging activity of the extract on NO radicals and hydro-
peroxide radicals arising from linoleic acid peroxydation
was not quite different. Upon fractionation, the scaven-
ging activity varied considerably within the fractions.
With NO assays, the fraction F2 was the most active
while in β carotene – linoleic acid assay, the extract was
more active than all the fractions. The onset of lipid oxi-
dation in the model system used in this study was initi-
ated by oxygen. The oxygen chelating activities of the
extract and fractions corresponded to greater reduction
in lipid oxidation.
Discussion
The C. bauchiense ethyl acetate extract was found to
express antifungal activity on dermatophytes and yeasts
including T. rubrum, T. Mentagrophytes and Candida
albicans with MIC varying between 0.125 and 1 mg/ml.
Table 1 Antifungal activity of C. bauchiense ethyl acetate extract and fractions
Parameters Extract (mg/ml) Fractions (mg/ml) Reference (μg/ml)
F1 F2 F3 F4 F5 F6
Yeasts
C. albicans 1663 CMI 1 >16 >16 4 2 2 >16 1
CMF 16 >16 >16 >16 8 16 >16 1
CMI/CMF 16 - - - 4 8 - 1
C. albicans 2091 CMI 0.25 >16 >16 4 4 4 >16 1
CMF >16 >16 >16 16 16 16 >16 1
CMI/CMF - - - 4 4 4 - 1
C. albicans 24433 CMI 0.5 >16 >16 4 4 4 >16 1
CMF 2 >16 >16 16 16 16 >16 1
CMI/CMF 4 - - 4 4 4 - 1
C. lusitania CMI 2 >16 >16 8 8 4 >16 16
CMF >16 >16 >16 >16 >16 16 >16 16
CMI/CMF - - - - - 4 - 1
C. parapsilosis CMI 4 >16 >16 4 4 4 >16 16
CMF >16 >16 >16 8 16 >16 >16 16
CMI/CMF - - - 2 4 - - 1
C. krusei CMI 2 >16 >16 4 4 4 >16 2
CMF >16 >16 >16 8 >16 >16 >16 2
CMI/CMF - - - 2 - - - 1
C. glabrata CMI 0.25 >16 >16 4 4 4 >16 16
CMF 2 >16 >16 8 16 8 >16 16
CMI/CMF 8 - - 2 4 2 - 1
C. tropicalis CMI 1 >16 >16 >16 8 8 >16 8
CMB >16 >16 >16 >16 >16 >16 >16 8
CMI/CMF - - - - - - - 1
C. neoformans CMI 0.5 >16 >16 0.5 0.5 0.5 >16 1
CMF >16 >16 >16 16 >16 >16 >16 1
CMI/CMF - - - 32 - - - 1
Dermatophytes
T. rubrum CMI 0.25 >16 >16 0.5 0.25 1 >16 1
CMF 2 >16 >16 1 0.5 2 >16 16
CMI/CMF 4 - - 2 2 2 - 16
T. mentagrophytes CMI 0 .25 >16 >16 0.5 0.5 1 >16 1
CMF 1 >16 >16 1 1 2 >16 >128
CMI/CMF 4 - - 2 2 2 - -
M. audouinii CMI 0.125 >16 >16 0.5 0.5 0.5 >16 1
CMF 8 >16 >16 0.5 0.5 1 >16 >128
CMI/CMF 8 - - 1 1 2 - -
M. gypseum CMI 0.125 >16 >16 0.5 0.5 1 >16 8
CMF 1 >16 >16 1 1 2 >16 128
CMI/CMF 8 - - 2 2 2 - 16
E. flocosum CMI 0.125 >16 >16 0.5 0.5 1 >16 1
CMF 1 >16 >16 0.5 0.5 1 >16 >128
CMI/CMF 8 - - 1 1 1 - -
Yeasts: reference = Nystatine; dermatophytes; reference = Gentamycin; − = undetermined, Fraction F1 was found to be inactive.
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Table 2 Effect of the C. bauchiense leaves ethyl acetate
extract and its fractions on in vitro free radical
scavenging and linoleic acid oxidation
DPPH NO β carotene -
linoleic acid
Extract 55.79 ± 5,40c 190.22 ± 1.50d 185.62 ± 1.17b
F2 389.38 ± 3.55
f 64.67 ± 2.80a 897.63 ± 2.00f
F3 30.95 ± 2.43
b 166.25 ± 1.30c 306.04 ± 1.50c
F4 211.94 ± 2.44
e 90.42 ± 2.00b 381.00 ± 1.00d
F5 104.11 ± 3.20
d 297.70 ± 1.00e 1015.5 ± 2.00g
F6 28.57 ± 2.11
b 1102.75 ± 2.10g 1086.66 ± 2.50h
L ascorbic acid 18.03 ± 4.15a 339.70 ± 1.15f 849.00 ± 2.13e
BHT 20.00 ± 1.00a / 94.00 ± 1.00a
Data are expressed as Mean ± S.E.M.; Values for a given column followed by
different letter as superscript are significantly different according to Waller
Dunkan multiple comparison procedure (at P < 0.05). Fraction F1 was found to
be inactive.
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ing unnecessary fractionation of the extract for antifun-
gal use. The results are relevant since Candida albicans
is the leading primary agent causing superficial and often
fatal disseminated infections in immunocompromised
patients [18]. On the other hand, Trichophyton rubrum
and Trichophyton mentagrophytes are the main cause of
athlete’s foot and onychomycoses in human beings, the
first one being the most prevalent superficial infection in
the developed world population [19] and the second
one, an infection that affect 2 – 13% of the population
worldwide and up to 30% of groups at high risk such as
the elderly people and diabetic patients [20].
The antifungal properties of C. bauchiense extract can
be linked to the presence of alkaloids, phenols, tannins,
triterpenes, and sterols. Indeed, members of these phyto-
chemical classes of compounds are known to possess
antimicrobial activities [21]. The fractions F3, F4 and F5
were found to be more active than other fractions. These
fractions are similar in that they all contain alkaloids and
sterols [2]. These groups of compounds may be respon-
sible for the antifungal activity.
The CMF/CMI ratio was generally less than 4, indicat-
ing the fungicidal activity of the C. bauchiense extract on
both dermatophytes and yeasts [22]. Also, these results
may highlight similar mechanism of action of the active
compound of the C. bauchiense ethyl acetate extract on
both yeasts and dermatophytes.
Differences in sensibility among strains could be due
to their genetic content. This is an evidence for the
necessity of antibiogram prior to antifungal prescription.
It is particularly important because inappropriate anti-
fungal drugs enhance fungal resistance [23]. The results
thus obtained could explain the traditional use of the
C. bauchiense leaves in the treatment of gastrointestinal
infections.Free-radicals are generated continuously in the body
due to metabolism and diseases [24]. In order to protect
themselves against free radicals, organisms are endowed
with endogenous (catalase, superoxide dismutase, gluta-
thione peroxidase/reductase) and exogenous (C and E
vitamins, carotene, uric acid) defense systems. These
defense systems are not sufficient in critical situations
such as oxidative stress, contamination, UV exposure,
microbial infections, etc. where the production of free
radicals significantly increases [25]. There is increasing
evidence that indigenous antioxidants may be useful in
preventing the deleterious consequences of oxidative
stress and there is increasing interest in the protective
biochemical functions of natural antioxidants contained
in spices, herbs and medicinal plants.
Many available methods are used to evaluate plant ex-
tracts for their antioxidant activity. Unfortunately, antioxi-
dant activities of plant extracts cannot be evaluated by any
single method, due to the complex nature of phytochemi-
cals [26]. Two or more methods should always be
employed in order to evaluate the total antioxidative effects
of vegetables [27]. Therefore, three complementary test
methods were used to evaluate the antioxidant capacities of
the extract and fractions of C. bauchiense leaves. Diphenyl-
picrylhydrazyl (DPPH), Nitric oxide (NO) and β-carotene -
linoleic acid. DPPH° radical scavenging method has been
proven to be good because its results are not affected
by substrate polarity. However, β- carotene/linoleic acid
method has the advantage of adding effective in situ lipid
oxidation to the system. It is a commonly used model to
analyze the antioxidant activity of the plant extracts because
β-carotene is extremely sensitive to free radical mediated
oxidation of linoleic acid [28].
The extract and fractions were able to reduce the stable
free radical of DPPH to the yellow coloured diphenylpi-
crylhydrazine. The potential decrease in the concentration
of DPPH radical is due to the scavenging ability of the
C. bauchiense leaves extract.
In the β – carotene/linoleic acid, oxidation of linoleic
acid occurs due to the production of reactive oxygen
species formed from halogenated water, this initiates
β-carotene oxidation leading to discoloration [29]. The
C. bauchiense extract and fractions inhibited β- caro-
tene oxidation, suggesting that the extract and fractions
inhibit the conjugated diene hydroperoxides arising from
linoleic acid oxidation that are known to be carcinogenic.
Especially, the extract and non polar fractions exhibited
stronger activity than polar ones. This activity could be
related to the polarity of tested compound which enable
them to be well dissolved in the emulsion.
Nitric oxide (NO) has been associated with a variety of
physiological processes in the human body since it was
identified as a novel signal molecule [30]. Besides its role
in physiologic processes, it also participates in pathogenic
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muscle diseases, inflammatory bowel disease, sepsis and
septic shock, primary headaches, HIV-associated demen-
tia, multiple sclerosis and stroke. Additionally, increasing
evidence shows that NO modulates neurotoxin induced
cell damage and is involved in neuronal cell death in
Parkinson’s disease (PD) and other neurodegenerative
disorders such as Alzheimer disease [31-33]. This un-
desired activity of NO is due to its ability to modulate
iron catalyzed oxidation reactions such as the O2 –
driven Fenton reaction, which produces powerful oxi-
dants such as the hydroxyl radical (·OH) and metalloxo
complexes. So, it is very important to investigate the NO
scavenging potential of the plant extract. In the present
study, the nitrite oxide produced by sodium nitroprusside
in standard phosphate saline buffer at 25°C was reduced
by the C. bauchiense extract and its fractions. This extract
may have the property to counteract the effect of NO for-
mation and in turn may be of considerable interest in pre-
venting the ill effects of excessive NO generation in the
human body. This may be due to the antioxidant princi-
ples in the extract which compete with oxygen to react
with NO·, thereby inhibiting the generation of nitrite.
Moreover, the scavenging activity may also help to arrest
the chain of reactions initiated by excess generation of NO
that are detrimental to human health.
Phenolic compounds are known as powerful chain break-
ing antioxidants. Phenols are very important plant consti-
tuents because of their scavenging ability due to their
hydroxyl groups [34]. It has been recognized that flavonoids
have antioxidant activity and their effects on human nutri-
tion and health are considerable. The mechanisms of action
of flavonoids are through scavenging processes [35]. These
substances contain hydroxyl functional groups, responsible
for antioxidant effect in plants [35].
The presence of phenols and flavonoids was reported
in the ethyl acetate extract of dry leaves of C. bauchiense
[1]. Thus, the antioxidant potential of the C. bauchiense
extract and its fractions could be attributed to the pres-
ence of these classes of compounds. Indeed, for each
antioxidant test, the most active fraction possesses at
least one of the two classes of compounds [1].
Fractionation of C. bauchiense ethyl acetate extract en-
hanced antioxidant activity in some fractions. The greatest
activity in these fractions could be related to the distribu-
tion of phenols and flavonoids compound. Considering
the antioxidant activity of the C. bauchiense extract on the
three systems used and the numerous origins of reactive
oxygen species in human body, it may be unnecessary to
fractionate this extract for its antioxidant property.
Conclusion
C. bauchiense leaves’ ethyl acetate extract contains com-
pounds with antifungal properties, which can be used asantimicrobial agents in pharmaceuticals and natural ther-
apies of infectious diseases in humans. The antioxidant
activity of the C. bauchiense extract indicates that it has a
protective effect against reactive oxygen species and can
therefore be used as a natural preservative ingredient.
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